Clinical Trial Update: A Retrospective Study of the Role of Thiazolidinediones to Reduce the Incidence of Atrial Arrhythmias

View source ↗

Summary

This retrospective study investigates whether thiazolidinediones could reduce atrial fibrillation incidence; the trial status is terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation

Drugs mentioned

• PIOGLITAZONE (Pioglitazone)
• Rosiglitazone (rosiglitazone)

Snippet

Sponsor: Emory University | Conditions: Atrial Fibrillation | Status: TERMINATED